EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
16.73
-1.33 (-7.38%)
Jun 1, 2026, 4:00 PM EDT - Market closed
EUDA Health Holdings Revenue
In the year 2025, EUDA Health Holdings had annual revenue of $6.82M with 70.04% growth. EUDA Health Holdings had revenue of $3.76M in the half year ending December 31, 2025.
Revenue (ttm)
$6.82M
Revenue Growth
+70.04%
P/S Ratio
7.34
Revenue / Employee
$58,293
Employees
123
Market Cap
50.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.82M | 2.81M | 70.04% |
| Dec 31, 2024 | 4.01M | 304.55K | 8.22% |
| Dec 31, 2023 | 3.71M | -57.84K | -1.54% |
| Dec 31, 2022 | 3.76M | -794.23K | -17.42% |
| Dec 31, 2021 | 4.56M | -4.32M | -48.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Offerpad Solutions | 487.19M |
| Altisource Portfolio Solutions | 175.12M |
| Star Holdings | 124.46M |
| Comstock Holding Companies | 62.86M |
| Fangdd Network Group | 50.73M |
| American Strategic Investment Co. | 38.32M |
| J.W. Mays | 21.75M |
| Seritage Growth Properties | 15.55M |
EUDA News
- 12 hours ago - EUDA Health regains Nasdaq compliance - TheFly
- 12 hours ago - EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask - GlobeNewsWire
- 12 hours ago - EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency - GlobeNewsWire
- 25 days ago - EUDA Health Holdings Ltd trading halted, volatility trading pause - TheFly
- 25 days ago - EUDA Health Holdings Ltd trading resumes - TheFly
- 4 weeks ago - EUDA Health Holdings Ltd trading halted, volatility trading pause - TheFly
- 4 weeks ago - EUDA Health Holdings Ltd trading resumes - TheFly
- 4 weeks ago - EUDA Highlights Shenzhen Inno's Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development - GlobeNewsWire